FindTrial
Sign In

"Clinical investigation on the efficacy of ionic contra-viral combined with carbon dioxide fractional laser for the treatment of plantar warts.

The efficacy of topical cedilanid and furosemide combined with carbon dioxide fractional laser in the treatment of plantar warts: a clinical study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095276
Enrollment
Unknown
Registered
2025-01-04
Start date
2024-03-19
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

plantar wart

Interventions

control group:Refrigerating group
experimental group:ionic contra-viral therapy

Sponsors

Liyang Peoples Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged over 18 years old, each person has at least 2 warts, with a diameter greater than or equal to 3mm;

Exclusion criteria

Exclusion criteria: 1.Within 60 days of having received other treatment for a wart; 2.Lactating patients and patients with cardiovascular disease.

Design outcomes

Primary

MeasureTime frame
Wart clearance rate;—

Secondary

MeasureTime frame
Patient satisfaction;Incidence of adverse reactions;—

Countries

China

Contacts

Public ContactLi Mi

Liyang People's Hospital

846768762@qq.com+86 519 68091839

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026